• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Okura Miyuki  大藏 美幸

ORCIDConnect your ORCID iD *help
… Alternative Names

大藏 美幸  オオクラ ミユキ

Less
Researcher Number 30647657
Affiliation (Current) 2025: 獨協医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help 2021 – 2023: 獨協医科大学, 医学部, 講師
2019 – 2020: 福井大学, 学術研究院医学系部門, 助教
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related
Except Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords
Principal Investigator
がん幹細胞 / 多発性骨髄腫 / レナリドマイド / 抗アポトーシス蛋白 / CD49e / 骨髄腫 / レナリドミド / 骨髄腫幹細胞 / survivin
Except Principal Investigator
免疫療法 … More / 化学療法 / エピゲノム修飾 / アポトーシス抵抗性 / 薬物治療学 / 血液腫瘍学 / 細胞療法 / 分子標的治療 Less
  • Research Projects

    (2 results)
  • Research Products

    (3 results)
  • Co-Researchers

    (3 People)
  •  Pharmacologically-directed termination of anti-apoptosis to overcome drug resistance in acute leukemia.

    • Principal Investigator
      Yamauchi Takahiro
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      University of Fukui
  •  Survivinを標的とした骨髄腫幹細胞に対する新規治療戦略の開発Principal Investigator

    • Principal Investigator
      大藏 美幸
    • Project Period (FY)
      2019 – 2025
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Dokkyo Medical University
      University of Fukui

All 2023 2021 2019

All Journal Article Presentation

  • [Journal Article] Combining Inotuzumab Ozogamicin (IO) with PARP Inhibitors, Olaparib and Talazoparib, Exerts Synergistic Cytotoxicity By Inhibiting the Repair of IO-Induced DNA Strand Breaks in IO-Resistant ALL Cells2023

    • Author(s)
      Ida N、Okura M、Hosono N、Yamauchi T
    • Journal Title

      Blood

      Volume: 142 Issue: Supplement 1 Pages: 5804-5804

    • DOI

      10.1182/blood-2023-173907

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07239
  • [Journal Article] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience International Journal of Hematology.2021

    • Author(s)
      Hosono N, Okura M, Morita H, Itoh K, Araie H, Matsuda Y, Yamauchi T.
    • Journal Title

      Int J Hematol. 2021

      Volume: 113 Issue: 3 Pages: 362-369

    • DOI

      10.1007/s12185-020-03023-4

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07239
  • [Presentation] The clinical significance of surface markers in multiple myeloma in the era of novel agents2019

    • Author(s)
      Miyuki Okura, Naoko Hosono, Takahiro Yamauchi
    • Organizer
      日本血液学会
    • Data Source
      KAKENHI-PROJECT-19K16857
  • 1.  Yamauchi Takahiro (90291377)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 2.  細野 奈穂子 (50509312)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 3.  根来 英樹 (40444228)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi